Arab FinanceDr. Ali Al-Ghamrawi, Chairman of the Egyptian Medicines Authority, witnessed the signing of a cooperation protocol between DAF and GS1 Egypt regarding the drug tracking project and its importance in ensuring the safety and effectiveness of drugs in Egypt, according to what he stated. statement cabinet.
The protocol comes as part of the executive steps to continue tightening control over the drug market and confront the challenges facing the health sector, including combating counterfeit and non-compliant medicines, reducing the illicit circulation of medicines by implementing a drug tracking system, and ensuring that the medicines available in the markets are of high quality. High and certified, ensuring proper circulation and identifying drug needs within an integrated system.
He stressed that the project represents a strategic step aimed at implementing an integrated system to track all pharmaceutical packages from the moment they are produced until they reach the patient, which enhances the transparency and security of the Egyptian medicine system, and that the pharmaceutical tracking system will rely on unique serial numbers for each package, which allows it to be followed up. Strictly from the moment of production, through the shipping and distribution processes, and even retrieval if necessary.
It will rely on programs compatible with international standards, so that the Egyptian Medicines Authority will be able to implement unprecedented monitoring rules. The pharmaceutical tracking system will enable us to locate any product in the smallest villages and the most remote governorates, as well as allow us to follow the life cycle of the product from raw materials to the final product, which enhances our ability to monitor the market accurately.
He added that the project has a positive impact on protecting the health of citizens and ensuring the safety of pharmaceutical preparations by preventing tampering with the pharmaceutical supply chain. It will help combat monopoly and smuggling, manage pharmaceutical stocks strategically while ensuring the continuous availability of medicines, and contribute to helping monitor the spread of diseases and take rapid measures. And effective.
Related news
